发明名称 |
USES OF MONOCLONAL ANTIBODY 8H9 |
摘要 |
This invention provides a composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a suitable carrier. This invention provides a pharmaceutical composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a pharmaceutically acceptable carrier. This invention also provides an antibody other than the monoclonal antibody 8H9 comprising the complementary determining regions of monoclonal antibody 8H9 or a derivative thereof, capable of binding to the same antigen as the monoclonal antibody 8H9. This invention provides a substance capable of competitively inhibiting the binding of monoclonal antibody 8H9. This invention also provides an isolated scFv of monoclonal antibody 8H9 or a derivative thereof. This invention also provides the 8H9 antigen. This invention also provides a method of inhibiting the growth of tumor cells comprising contacting said tumor cells with an appropriate amount of monoclonal antibody 8H9 or a derivative thereof. |
申请公布号 |
US2014161814(A1) |
申请公布日期 |
2014.06.12 |
申请号 |
US201313958902 |
申请日期 |
2013.08.05 |
申请人 |
SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH |
发明人 |
CHEUNG Nai-Kong V. |
分类号 |
C07K16/30 |
主分类号 |
C07K16/30 |
代理机构 |
|
代理人 |
|
主权项 |
1. An antibody secreted by hybridoma 8H9.
|
地址 |
New York NY US |